Nefazodone in diabetic neuropathy: response and biology.
Goodnick
P J
PJ
Breakstone
K
K
Kumar
A
A
Freund
B
B
DeVane
C L
CL
D000368:Aged; D000700:Analgesics / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy; D003929:Diabetic Neuropathies / Q000097:blood / Q000188:drug therapy*; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement; D010879:Piperazines; D012701:Serotonin / Q000097:blood; D014230:Triazoles / Q000627:therapeutic use*
D000700:Analgesics; D001786:Blood Glucose; D006442:Glycated Hemoglobin; D010879:Piperazines; D012701:Serotonin; D014230:Triazoles; C051752:nefazodone